1-20 of 49
echocardiography, transthoracic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective, Comprehensive Cardiac Assessment in Patients Receiving BTK Inhibitor Therapy

Chloe Pek Sang Tang, MBBS, FRACP, Andre La Gerche, Julie McMullen, BSc(Hons) PhDFCSANZ FAHA, Erin Howden, Sasanka M. Handunnetti, MBBS, FRACP, FRCPA, Isaac Goncalves, MBBS PhDFRACP, Jenny Ooi, Constantine S. Tam, MBBS (Hons), MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4301.
https://doi.org/10.1182/blood-2019-129808
Published: 2019
Journal Articles

JAK2V617F-Mediated Endothelial Dysfunction Promotes Congestive Heart Failure in a Murine Model of Myeloproliferative Neoplasm

Melissa Castiglione, BS, Christopher Mazzeo, BS, Ya-Ping Jiang, Juei-Suei Chen, Wei Yin, Richard Lin, Huichun Zhan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 7.
https://doi.org/10.1182/blood-2019-131372
Published: 2019
Journal Articles

Implementation of a Cardio Oncology Protocol in Uruguay

Pía Oldan, MD, Andreina Gomez, MD, Gabriel Parma, MD, Cecilia Guillermo, MD, Lilián Díaz, MD, Matilde Boada, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 5888.
https://doi.org/10.1182/blood-2019-127068
Published: 2019
Journal Articles

The Yield of Echocardiography in the Diagnosis of Infective Endocarditis in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia

Ghazi S. Alotaibi, Irwindeep Sandhu, MD FRCPC, Joseph M. Brandwein, MD FRCPC, Lalit Saini, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5177.
https://doi.org/10.1182/blood-2018-99-120018
Published: 2018
Journal Articles

Hypofibrinogenemia in Patient with Extended Exposure to Argatroban Therapy

Mustafa Saudi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5035.
https://doi.org/10.1182/blood-2018-99-117765
Published: 2018
Journal Articles

Improvement in Global Longitudinal Strain (GLS) Correlates with NT-Probnp Response in Patients with Cardiac Amyloidosis Treated on a Phase 1b Study of Anti-Amyloid Mab Cael-101

Divaya Bhutani, MD, Siyang Leng, MD, Andrew Eisenberger, MD, Mathew S. Maurer, MD, Sofia Shames, MD, Jeff Goldsmith, PhD, Suzanne Lentzsch, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 958.
https://doi.org/10.1182/blood-2018-99-118464
Published: 2018
Journal Articles

Predictive Factors for Survival in Sickle Cell Disease: A Cohort Study Using Etendard Data

Laurent Savale, MD PhD, Gylna Loko, MD, François Lionnet, Bernard Maitre, Anoosha Habibi, Jocelyn Inamo, Dora Bachir, MD, Françoise Driss, Vincent Audard, MDPhD, Etienne Audureau, Marc Humbert, Gerald Simonneau, Frédéric Galactéros, MDPhD, Florence Parent, Pablo Bartolucci, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 7.
https://doi.org/10.1182/blood-2018-99-113767
Published: 2018
Journal Articles

Comparison of Different Techniques to Identify Cardiac Involvement in Immunoglobulin Light Chain Amyloidosis

Mohammed A Aljama, MBBS,FRCPC, M Hasib Sidiqi, MBBS, Angela Dispenzieri, MD, Morie A. Gertz, MD, Martha Q. Lacy, MD, Francis K. Buadi, MB, CHB, David Dingli, MD PhD, Eli Muchtar, MD, Amie Fonder, PA-C, Suzanne R. Hayman, MD, Miriam Hobbs, CNP, Wilson I Gonsalves, MD, Rahma Warsame, MD, Taxiarchis Kourelis, MD, Lisa Hwa, CNP, DNP, Prashant Kapoor, MD, Nelson Leung, MD, Ronald S. Go, MD, Robert A. Kyle, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3182.
https://doi.org/10.1182/blood-2018-99-117627
Published: 2018
Journal Articles

Characterization of Cardiovascular Adverse Events and B-Type Natriuretic Peptide Levels in Patients with Multiple Myeloma Who Are Treated with Carfilzomib

Hang Quach, MDFRACP,FRCPA,MBBS, Khue Minh Nguyen, Matthew Ku, MBBS, FRACP, FRCPA, Ali Bazargan, MBBS FRACP FRCPA, Robin J Filshie, PhDFRACP,FRCPA, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Lisa Catherine Demosthenous, MPH, BSN, David Prior, MBBS FRACP PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1956.
https://doi.org/10.1182/blood-2018-99-113802
Published: 2018
Journal Articles

Various Gvhd Prophylaxis Regimens Influence Differently T-Memory Cell Subsets Recovery after Allogeneic Stem Cell Transplantation in Leukemia Patients

Mikhail Drokov, Natalia Popova, MD, Elena Parovichnikova, MD PhD, Larisa Kuzmina, PhD, Julia Davydova, Nikolay Kapranov, Ekaterina Mikhaltsova, PhD, Olga Koroleva, Vera Vasilyeva, Daria Dubnyak, Zoya Konova, Anna Sidorova, Ekterina Usikova, Anna Dmitrova, Irina V. Galtseva, PhD, Mikhail Maschan, PhD, Valery G. Savchenko, MD PhD academician
Journal: Blood
Blood (2018) 132 (Supplement 1): 5717.
https://doi.org/10.1182/blood-2018-99-114688
Published: 2018
Journal Articles

Long-Term Update from the Open-Label Extension of the NEURO-TTR Study in Patients with Hereditary Transthyretin Amyloidosis

Thomas Brannagan, Annabel K. Wang, Teresa Coelho, Marcia Waddington Cruz, Michael J. Polydefkis, Peter J. Dyck, Violaine Plante-Bordeneuve, John L. Berk, Fabio Barroso, Giampaolo Merlini, Isabel Conceição, Steven G. Hughes, Jesse G. Kwoh, Shiangtung W. Jung, Spencer Guthrie, Michael Pollock, Merrill D. Benson, Morie A. Gertz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 498.
https://doi.org/10.1182/blood-2018-99-116995
Published: 2018
Journal Articles

The High Output State of Sickle Cell Patients: Associations with Anemia-Related Organ Damage

Bart J. Biemond, MD PhD, Tim R. de Back, MD, Charlotte F.J. Van Tuijn, MPH, PhD, Erfan Nur, MD PhD, Berto J. Bouma, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3661.
https://doi.org/10.1182/blood-2018-99-117501
Published: 2018
Journal Articles

Pulmonary Hypertension Independently Shortens Survival of Patients with Myeloproliferative Neoplasms

Jiwon Kim, MD, Spencer Krichevsky, BS, Neil K Mehta, MD, Sara Rodriguez-Diego, MD, Meridith P Pollie, BS, Richard T Silver, MD, Andrew I Schafer, MD, Ellen K Ritchie, MD, Mia Wiese, BS, Claudia Sosner, BA, Evelyn M Horn, MD, Richard B Devereux, MD, Jonathan W Weinsaft, MD, Joseph Scandura, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 324.
https://doi.org/10.1182/blood.V130.Suppl_1.324.324
Published: 2017
Journal Articles

Atrial Fibrillation (AF) and Ibrutinib, a Monocentric Experience: Should Cardiological Evaluation be a Guide in Clinical Practice?

Gianluigi Reda, MD, Ramona Cassin, Veronica Mattiello, Tatiana Tonella, Diana Giannarelli, PhD, Bruno Fattizzo, MD, Francesco Onida, MD, Ferdinando Maria Massari, Agostino Cortelezzi, Prof
Journal: Blood
Blood (2017) 130 (Supplement 1): 1747.
https://doi.org/10.1182/blood.V130.Suppl_1.1747.1747
Published: 2017
Journal Articles

Prospective Study of Cardiac Events during Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma

Robert Frank Cornell, MD, Bonnie Ky, MD, Brendan M Weiss, MD, Liping Du, PhD, Joseph R Carver, MD, Adam D. Cohen, MD, Brian G Engelhardt, MD, Alfred L. Garfall, MD, Stacey A Goodman, MD MS, Shelton Lacy Harrell, MSN, Adetola A. Kassim, MD MS, Trafina Jadhav, PhD, Madan Jagasia, MD MBBS, MS, Javid Moslehi, MD, Rupal O'Quinn, MD, Michael R. Savona, MD, David Slosky, MD, Amanda Smith, Edward A. Stadtmauer, MD FACP, Dan T. Vogl, MD, Racquel Innis-Shelton, MD, Adam Waxman, MD, Daniel Lenihan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1855.
https://doi.org/10.1182/blood.V130.Suppl_1.1855.1855
Published: 2017
Journal Articles

The First Case of Primary Cardiac Lymphoma, Diffuse Large B-Cell Type, Successfully Treated with EPOCH-R

Sherise Chantell Rogers, MD MPH, Owen A. O'Connor, MD PhD, Glen Granati, MD, Kavitha Yaddanapudi, MD
Journal: Blood
Blood (2016) 128 (22): 5418.
https://doi.org/10.1182/blood.V128.22.5418.5418
Published: 2016
Journal Articles

Cardiotoxicity Secondary to Tyrosine Kinase Inhibitors 2nd Generation in Mexican Patients with Chronic Myeloid Leukemia

Manuel Ayala, MD, Jacqueline Domínguez, NL, Iván Bonilla, MD
Journal: Blood
Blood (2016) 128 (22): 5430.
https://doi.org/10.1182/blood.V128.22.5430.5430
Published: 2016
Journal Articles

The Triple Combination of the CD20 Antibody Obinutuzumab with the Bcl-2 Inhibitor Venetoclax (GDC-199) and the MDM2 Inhibitor Idasanutlin Results in Superior Efficacy and Long Term Response in Wildtype p53 NHL Tumor Models

Frank Herting, PhD, Thomas Friess, PhD, Pablo Umaña, PhD, Middleton Steven, PhD, Christian Klein, PhD
Journal: Blood
Blood (2016) 128 (22): 4178.
https://doi.org/10.1182/blood.V128.22.4178.4178
Published: 2016
Journal Articles

The CLL-IPI applied in a population-based cohort

Clinical Trials & Observations
Caspar da Cunha-Bang, Ilse Christiansen, Carsten Utoft Niemann
Journal: Blood
Blood (2016) 128 (17): 2181–2183.
https://doi.org/10.1182/blood-2016-07-724740
Published: 2016
Journal Articles

Acute Common Iliac Artery Thrombosis with Concurrent Pulmonary Embolism Revealing AML M2: Role of Elevated Plasma Tissue Factor Activity

Hind Bennani, PharmD, Raphaël Coscas, MD, Marc Coggia, MD, Patrick Van Dreden, PhD, Marc Vasse, PharmD, Jacques Vargaftig, MD
Journal: Blood
Blood (2015) 126 (23): 4722.
https://doi.org/10.1182/blood.V126.23.4722.4722
Published: 2015